查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722930

血浆衍生物市场规模、份额、趋势及预测（按类型、应用、最终用户和地区），2025 年至 2033 年

Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球血浆衍生物市场规模价值为 482.7 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 759 亿美元，2025 年至 2033 年的复合年增长率为 5.2%。北美目前占据市场主导地位，到 2024 年市占率将超过 48.9%。慢性病盛行率的上升、先进的血浆采集基础设施、技术创新、老年人口的增长以及治疗应用的扩大是推动该地区市场成长的一些因素。

血浆衍生物是透过分馏过程从血浆中获得的特定蛋白质的浓缩物。因子 VIII、免疫球蛋白、白蛋白、超免疫球蛋白、因子 IX 和新鲜冷冻血浆是一些常见的血浆衍生物。它们富含蛋白质、矿物质、盐、荷尔蒙、维生素和蛋白酶抑制剂，因此被广泛用于杀灭导致B型肝炎、甲型血友病、出血性疾病、免疫缺陷、丙型肝炎、低丙种球蛋白血症、乙型血友病和人类免疫缺陷病毒（HIV）的病毒。此外，血浆衍生物有助于增强营养、控制体温和血液凝固、维持渗透压、增强呼吸和排泄、调节酸碱平衡。血浆衍生物通常储存在医院、诊所、诊断中心和输血中心。

血浆衍生物市场趋势：

老年人口的不断增加更容易患上传染病，这为市场带来了积极的前景。血浆中含有免疫球蛋白，在免疫系统的形成中起着重要作用，并维持血管内的渗透压，从而进一步预防免疫缺陷病和血友病的发病。此外，透过恢復期血浆疗法治疗冠状病毒病 (COVID-19) 患者的产品广泛采用有利于市场成长。此外，分馏过程中的各种技术创新有助于分离蛋白质浓缩物和血浆中的各种成分以用于临床目的，为市场成长提供了相当大的推动力。与此相符的是，先进保存方法的发展以及用于开发有针对性的治疗产品的封装程序的显着改进进一步促进了市场的成长。其他因素，包括医疗保健行业的显着增长、人们对血液和血浆捐赠的认识不断提高以及政府为推广捐血活动而实施的各种倡议，预计将推动市场进一步增长。

本报告回答的关键问题

  • 什么是血浆衍生物？血浆衍生性商品市场有多大？
  • 2025 年至 2033 年期间全球血浆衍生物市场的预期成长率为何？
  • 推动全球血浆衍生物市场发展的关键因素有哪些？
  • 根据类型，全球血浆衍生物市场的主要部分是什么？
  • 根据应用，全球血浆衍生物市场的主要部分是什么？
  • 根据最终用户来看，全球血浆衍生物市场的主要细分市场是什么？
  • 全球血浆衍生物市场的主要区域有哪些？
  • 全球血浆衍生物市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球血浆衍生物市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 白蛋白
  • 第八因子
  • 凝血因子IX
  • 免疫球蛋白
  • 高免疫球蛋白
  • 其他的

第七章：市场区隔：依应用

  • 血友病
  • 低丙种球蛋白血症
  • 免疫缺乏疾病
  • 血管性血友病
  • 其他的

第八章：市场区隔：按最终用户

  • 医院
  • 诊所
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Baxter International Inc.
    • Bayer AG
    • CSL Limited
    • Fusion Health Care Pvt. Ltd.
    • Grifols SA
    • Kedrion SpA
    • LFB SA
    • Octapharma AG
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
Product Code: SR112025A5371

The global blood plasma derivatives market size was valued at USD 48.27 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 75.9 Billion by 2033, exhibiting a CAGR of 5.2% from 2025-2033. North America currently dominates the market, holding a market share of over 48.9% in 2024. The rising chronic disease prevalence, advanced plasma collection infrastructure, technological innovations, growing geriatric population, and expanding therapeutic applications are some of the factors driving the market growth in this region.

Blood plasma derivatives are concentrates of specific proteins prepared from plasma that are obtained through fractionation process. Factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX and fresh frozen are some of the common blood plasma derivatives. They are rich in proteins, minerals, salts, hormones, vitamins and protease inhibitors, due to which they are widely used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B and human immunodeficiency virus (HIV). Apart from this, blood plasma derivatives assist in enhancing nutrition, controlling body temperature and coagulation of blood, maintaining osmotic pressure, enhancing respiration and excretion, and regulating acid-base balance. Blood plasma derivatives are commonly stored at hospitals, clinics, diagnostic centers and blood transfusion centers.

Blood Plasma Derivatives Market Trends:

The increasing geriatric population that are more susceptible to developing infectious diseases are creating a positive outlook for the market. Blood plasma contains immunoglobulins that play an important role in the development of immunity and maintain the osmotic pressure in blood vessels, which further prevents the onset immunodeficiency disorders and hemophilia. Moreover, the widespread product adoption to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is favoring the market growth. Additionally, various technological innovations in the fractionation process that aids in separating protein concentrates and various components of blood plasma for clinical purposes are providing a considerable boost to the market growth. In line with this, the development of advanced preservation methods, along with the significant improvements in encased procedures for developing targeted therapeutic products are further augmenting the market growth. Other factors, including significant growth in the healthcare industry, increasing awareness regarding blood and plasma donation and the implementation of various government initiatives to promote blood donation camps, are anticipated to drive the market further toward growth.

Key Market Segmentation:

Breakup by Type:

  • Albumin
  • Factor VIII
  • Factor IX
  • Immunoglobulin
  • Hyperimmune Globulin
  • Others

Breakup by Application:

  • Hemophilia
  • Hypogammaglobulinemia
  • Immunodeficiency Diseases
  • Von Willebrand's Disease
  • Others

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report

  • 1.What are blood plasma derivatives?
  • 2.How big is the blood plasma derivatives market?
  • 3.What is the expected growth rate of the global blood plasma derivatives market during 2025-2033?
  • 4.What are the key factors driving the global blood plasma derivatives market?
  • 5.What is the leading segment of the global blood plasma derivatives market based on type?
  • 6.What is the leading segment of the global blood plasma derivatives market based on application?
  • 7.What is the leading segment of the global blood plasma derivatives market based on end user?
  • 8.What are the key regions in the global blood plasma derivatives market?
  • 9.Who are the key players/companies in the global blood plasma derivatives market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Plasma Derivatives Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Albumin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Factor VIII
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Factor IX
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Immunoglobulin
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Hyperimmune Globulin
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Hemophilia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hypogammaglobulinemia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunodeficiency Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Von Willebrand's Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 CSL Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Fusion Health Care Pvt. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Grifols S.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Kedrion S.p.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 LFB S.A.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Octapharma AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takeda Pharmaceutical Company Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Blood Plasma Derivatives Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Plasma Derivatives Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Blood Plasma Derivatives Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Blood Plasma Derivatives Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Blood Plasma Derivatives Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Blood Plasma Derivatives Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Blood Plasma Derivatives Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Blood Plasma Derivatives (Albumin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Blood Plasma Derivatives (Albumin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Blood Plasma Derivatives (Factor VIII) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Blood Plasma Derivatives (Factor VIII) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Blood Plasma Derivatives (Factor IX) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Blood Plasma Derivatives (Factor IX) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Blood Plasma Derivatives (Immunoglobulin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Blood Plasma Derivatives (Immunoglobulin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Blood Plasma Derivatives (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Blood Plasma Derivatives (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Blood Plasma Derivatives (Hemophilia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Blood Plasma Derivatives (Hemophilia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Blood Plasma Derivatives (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Blood Plasma Derivatives (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Blood Plasma Derivatives (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Blood Plasma Derivatives (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Blood Plasma Derivatives (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Blood Plasma Derivatives (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Blood Plasma Derivatives (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Blood Plasma Derivatives (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: North America: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: North America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: United States: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: United States: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Canada: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Canada: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Asia-Pacific: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Asia-Pacific: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: China: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: China: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Japan: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Japan: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: India: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: India: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: South Korea: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: South Korea: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Australia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Australia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Indonesia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Indonesia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Europe: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Europe: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Germany: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Germany: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: France: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: France: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: United Kingdom: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: United Kingdom: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Italy: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Italy: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Spain: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Spain: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Russia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Russia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Latin America: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Latin America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Brazil: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Brazil: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Mexico: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Mexico: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Middle East and Africa: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Middle East and Africa: Blood Plasma Derivatives Market: Breakup by Country (in %), 2024
  • Figure 84: Middle East and Africa: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Blood Plasma Derivatives Industry: SWOT Analysis
  • Figure 86: Global: Blood Plasma Derivatives Industry: Value Chain Analysis
  • Figure 87: Global: Blood Plasma Derivatives Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Plasma Derivatives Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Blood Plasma Derivatives Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Blood Plasma Derivatives Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Blood Plasma Derivatives Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Blood Plasma Derivatives Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Blood Plasma Derivatives Market: Competitive Structure
  • Table 7: Global: Blood Plasma Derivatives Market: Key Players